 Company Flooded with Opportunities to Demo Breakthrough UST Nanoemulsion Benefits and Serve Toll Production Demand in Pharmaceutical, Nutraceutical, and Personal Care Applications SOUTH EASTON, MA ACCESSWIRE September 29, 2021 Pressure BioSciences, Inc. OTCQB:PBIO PBI or the Company, a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food beverage industries, today announced it is advancing rapidly on plans to establish West and East Coast demonstration and tolling sites in the United States. The Company is currently in discussions with potential business partners to fulfill certain strategic objectives, including: i accelerating demonstrations of its patented Ultra Shear TechnologyTM USTTM platform for processing nanoemulsions, and ii developing GMP-compliant toll manufacturing capacity to provide efficient and readily available fee-for-service production demands from small to medium scale manufacturers. 